Back to Top
Go Back
Journal Photo for European Neuropsychopharmacology
Peer reviewed only Open Access

European Neuropsychopharmacology (ENP)

Publisher : Elsevier B.V.
Pharmacology Biological Psychiatry Psychiatry
Claim Your Journal Get PRC Visit Website
e-ISSN 1873-7862
p-ISSN 0924-977X
Issue Frequency Monthly
Impact Factor 6.1
Est. Year 1990
Mobile 31204853767
Country Netherlands The
Language English
APC YES
Impact Factor Assignee Google Scholar
Email ENP@elsevier.com

Journal Descriptions

An Official Journal of the European College of Neuropsychopharmacology European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery. European Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology (ECNP). Electronic usage: An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information. Average monthly article downloads for this journal: 29,000

European Neuropsychopharmacology (ENP) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Biological Psychiatry, Psychiatry, Mental Health, Psychology, Neurology, Clinical Neurology , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0924-977X, E-ISSN: 1873-7862, Established: 1990, Impact Factor: 6.1
  • Does Not Provide Crossref DOI

  • Indexed in: Scopus, WoS

  • Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Publications of ENP

Multi-omics data integration methods and their applications in psychiatric disorders
Mohammad Ali Moni April, 2023
To study mental illness and health, in the past researchers have often broken down their complexity into individual subsystems (e.g., genomics, transcriptomics, proteomics, clinical data) an...
Multi-omics data integration methods and their applications in psychiatric disorders
Mohammad Ali Moni April, 2023
To study mental illness and health, in the past researchers have often broken down their complexity into individual subsystems (e.g., genomics, transcriptomics, proteomics, clinical data) an...
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review
Pietro Liò February, 2022
Variation in the expression level and activity of genes involved in drug disposition and action in tissues of pharmacological importance have been increasingly investigated in patients treat...
SA97COMPUTATIONAL PSYCHIATRY MEETS GENETICS: REINFORCEMENT LEARNING IN EARLY PSYCHOSIS AND IN RELATION TO CLINICAL AND MOLECULAR GENETIC RISK FOR SCHI...
Graham Murray August, 2019
Computational psychiatry offers opportunities for increased mechanistic understanding of mental disorder and to aid in the integration between psychiatry and neuroscience. By developing an...
F133INVESTIGATING THE PHENOTYPIC MANIFESTATION OF SCHIZOPHRENIA WITH REGARDS TO GENERAL AND SPECIFIC PSYCHOPATHOLOGY IN ADOLESCENCE USING A BIFACTOR M...
Peter B Jones February, 2019
Background: There is growing support for a hierarchical structure of first and higher-order dimensions of psychopathological symptoms, however, little is known about how these dimensions rel...
A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome
Peter B Jones September, 2016
Metabolic complications are commonly found in people treated with clozapine. Reviews on the management of this problem have generally drawn conclusions by grouping different types of studies...
Association of birth weight and the development of antipsychotic induced adiposity in individuals with treatment resistant schizophrenia
Peter B Jones June, 2016
Though weight gain is a common side effect of antipsychotic treatment, there are no useful predictors of which patients are likely to be affected and to what degree. It has been shown that e...
Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF)
Peer Briken January, 2015
Serum levels of brain-derived neurotrophic factor (BDNF) are reduced in male-to-female transsexual persons (MtF) compared to male controls. It was hypothesized before that this might reflect...